FYERS
Home
/
Stocks
/
Results
/
Innova Captab Results

Innova Captab Results

Financial overview

CAGR%
Sales
Profits
Returns
ROE
10Y5Y3YTTM
-32%21%31%
-33%28%10%
---52%
24%22%15%14%

Peer Comparison

Symbol
SUNPHARMA
DIVISLAB
TORNTPHARM
ZYDUSLIFE
CIPLA
LAURUSLABS
MANKIND
DRREDDY
AUROPHARMA
LUPIN
INNOVACAP
PriceM.Cap (₹)PE RatioEPS (₹)EV/EBITDAAnnual PAT
1,849.9₹447476 Cr3712.0762.82₹11479 Cr
9,602₹254764 Cr87.134.04128.41₹2568 Cr
4,928.5₹189423 Cr86.8516.7297.06₹2163 Cr
1,180.3₹116658 Cr25.859.4262.53₹5040 Cr
1,399₹111484 Cr33.089.7757.87₹3879 Cr
2,026.2₹109943 Cr100.556.829.25₹889 Cr
2,500₹101712 Cr49.7913.7571.08₹1913 Cr
1,200.4₹101005 Cr31.355.3263.99₹4196 Cr
1,716₹99253 Cr26.7317.9596.84₹3505 Cr
2,100.7₹96031 Cr17.3730.95154.35₹5333 Cr
1,295.3₹7436 Cr47.577.7135.32₹141 Cr

Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
₹
%

Balance Sheet

Consolidated
Standalone
₹
%
Name
Equity And Liabilities
Share Capital
Total Reserves
Reserve excluding Revaluation Reserve
Shareholder's Funds
Secured Loans
Unsecured Loans
Deferred Tax Assets / Liabilities
Other Long Term Liabilities
Long Term Provisions
Total Non-Current Liabilities
Current Liabilities
Trade Payables
Other Current Liabilities
Short Term Borrowings
Short Term Provisions
Total Current Liabilities
Total Liabilities
Contingent Liabilities
Total Debt
Assets
Gross Block
Less Accumulated Depreciation
Net Block
Capital Work in Progress
Long Term Loans & Advances
Other Non Current Assets
Total Non-Current Assets
Current Assets Loans & Advances
Currents Investments
Inventories
Sundry Debtors
Cash and Bank
Other Current Assets
Short Term Loans and Advances
Total Current Assets
Net Current Assets (Including Current Investments)
Total Assets
Book Value
Adjusted Book Value
Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019
————————
₹57 Cr₹57 Cr₹57 Cr₹48 Cr₹12 Cr₹12 Cr₹12 Cr₹12 Cr
₹1034 Cr₹902 Cr₹774 Cr₹229 Cr₹197 Cr₹133 Cr₹98 Cr₹70 Cr
₹1034 Cr₹902 Cr₹774 Cr₹229 Cr₹197 Cr₹133 Cr₹98 Cr₹70 Cr
₹1091 Cr₹959 Cr₹831 Cr₹277 Cr₹209 Cr₹145 Cr₹110 Cr₹82 Cr
₹215 Cr₹244 Cr₹208 Cr₹62 Cr₹40 Cr₹6 Cr₹12 Cr₹26 Cr
₹0₹0₹0₹72 Cr₹27 Cr₹0₹0₹0
₹23 Cr₹95 L-₹15 Cr₹4 Cr₹2 Cr₹2 Cr₹2 Cr₹1 Cr
₹1 Cr₹1 Cr₹2 Cr₹9 Cr₹68 L₹48 L₹64 L₹21 L
₹12 Cr₹10 Cr₹9 Cr₹47 Cr₹18 Cr₹36 Cr₹56 L₹42 L
₹251 Cr₹256 Cr₹205 Cr₹194 Cr₹88 Cr₹44 Cr₹14 Cr₹28 Cr
————————
₹319 Cr₹202 Cr₹180 Cr₹158 Cr₹145 Cr₹112 Cr₹72 Cr₹62 Cr
₹69 Cr₹77 Cr₹58 Cr₹21 Cr₹28 Cr₹69 Cr₹12 Cr₹10 Cr
₹99 Cr₹66 Cr₹24 Cr₹98 Cr₹120 Cr₹33 Cr₹36 Cr₹40 Cr
₹30 Cr₹32 Cr₹32 Cr₹58 L₹22 Cr₹53 L₹10 Cr₹6 Cr
₹517 Cr₹376 Cr₹294 Cr₹278 Cr₹315 Cr₹215 Cr₹129 Cr₹117 Cr
₹1858 Cr₹1592 Cr₹1329 Cr₹748 Cr₹612 Cr₹404 Cr₹254 Cr₹228 Cr
₹0₹0₹0₹6 L₹7 L₹6 L₹1 Cr₹1 Cr
₹343 Cr₹336 Cr₹242 Cr₹235 Cr₹198 Cr₹45 Cr₹54 Cr₹72 Cr
————————
₹956 Cr₹901 Cr₹406 Cr₹216 Cr₹206 Cr₹107 Cr₹94 Cr₹90 Cr
₹114 Cr₹71 Cr₹49 Cr₹33 Cr₹23 Cr₹28 Cr₹21 Cr₹11 Cr
₹842 Cr₹830 Cr₹358 Cr₹183 Cr₹183 Cr₹79 Cr₹73 Cr₹78 Cr
₹16 Cr₹23 Cr₹341 Cr₹22 Cr₹3 L₹7 Cr₹0₹0
₹16 Cr₹7 Cr₹22 Cr₹101 Cr₹29 Cr₹48 Cr₹85 L₹1 Cr
₹40 Cr₹6 Cr₹50 L₹26 L₹28 L₹0₹0₹0
₹913 Cr₹865 Cr₹721 Cr₹306 Cr₹212 Cr₹134 Cr₹74 Cr₹80 Cr
————————
₹41 Cr₹0₹0₹0₹0₹0₹0₹0
₹283 Cr₹208 Cr₹144 Cr₹117 Cr₹128 Cr₹91 Cr₹65 Cr₹39 Cr
₹437 Cr₹332 Cr₹288 Cr₹265 Cr₹213 Cr₹139 Cr₹87 Cr₹91 Cr
₹4 Cr₹68 Cr₹87 Cr₹19 Cr₹2 Cr₹12 Cr₹5 Cr₹2 Cr
₹65 Cr₹33 Cr₹9 Cr₹13 Cr₹6 Cr₹3 Cr₹1 Cr₹1 Cr
₹114 Cr₹78 Cr₹80 Cr₹28 Cr₹50 Cr₹26 Cr₹22 Cr₹16 Cr
₹945 Cr₹719 Cr₹608 Cr₹442 Cr₹400 Cr₹270 Cr₹180 Cr₹148 Cr
₹428 Cr₹343 Cr₹314 Cr₹165 Cr₹85 Cr₹55 Cr₹51 Cr₹31 Cr
₹1858 Cr₹1592 Cr₹1329 Cr₹748 Cr₹612 Cr₹404 Cr₹254 Cr₹228 Cr
₹191₹168₹145₹58₹1,738₹1,207₹920₹687
₹191₹168₹145₹58₹43₹30₹23₹17

Cash Flow

Consolidated
Standalone
₹
%
Name
Profit Before Tax
Adjustment
Changes In working Capital
Cash Flow after changes in Working Capital
Cash Flow from Operating Activities
Cash Flow from Investing Activities
Cash Flow from Financing Activitie
Net Cash Inflow / Outflow
Opening Cash & Cash Equivalents
Cash & Cash Equivalent on Amalgamation / Take over / Merger
Closing Cash & Cash Equivalent
Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019
₹188 Cr₹171 Cr₹130 Cr₹92 Cr₹86 Cr₹46 Cr₹38 Cr₹25 Cr
₹58 Cr₹27 Cr₹37 Cr₹26 Cr₹15 Cr₹10 Cr₹14 Cr₹16 Cr
-₹103 Cr-₹111 Cr₹7 Cr-₹31 Cr-₹21 Cr-₹1 Cr-₹12 Cr-₹13 Cr
₹143 Cr₹88 Cr₹174 Cr₹87 Cr₹80 Cr₹55 Cr₹40 Cr₹28 Cr
₹117 Cr₹64 Cr₹146 Cr₹67 Cr₹59 Cr₹42 Cr₹31 Cr₹19 Cr
-₹107 Cr-₹152 Cr-₹499 Cr-₹91 Cr-₹188 Cr-₹20 Cr-₹6 Cr-₹9 Cr
-₹22 Cr₹92 Cr₹361 Cr₹27 Cr₹125 Cr-₹19 Cr-₹23 Cr-₹9 Cr
-₹12 Cr₹4 Cr₹8 Cr₹3 Cr-₹5 Cr₹3 Cr₹1 Cr₹54 L
₹16 Cr₹12 Cr₹4 Cr₹15 L₹5 Cr₹2 Cr₹75 L₹21 L
₹0₹0₹0₹0₹0₹50,000₹0₹0
₹3 Cr₹16 Cr₹12 Cr₹4 Cr₹15 L₹5 Cr₹2 Cr₹75 L

Fundamental Ratios

Consolidated
Standalone

Share Price Live Stats

Open (₹)1,297.60
Volume (₹)1.01 L
High (₹)1,322.90
Upper Circuit1,557.10
Low (₹)1,272.20
Lower Circuit1,038.10
Prev Close1,297.60
52W High (₹)1,353.50
Price1,295.30
52W Low (₹)622.00

Share Market Cap & Key Ratios Overview

M.Cap (₹)7435.52 Cr
Div. Yield (%)0.15
PE Ratio47.57
Debt to Equity0.31
Price to Book3.61
Book Value190.62
EPS (TTM)27.31
Face Value10.00
ROE (%)13.75

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .
LoginSign Up

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .
LoginSign Up

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
ZYDUSLIFENSE
CIPLANSE
LAURUSLABSNSE
MANKINDNSE
DRREDDYNSE
AUROPHARMANSE
LUPINNSE
INNOVACAPNSE
LTP
1W Low
1W High
Market cap (₹)
1849.9+12.6 (0.69%)
1832.20
1891.50
4,47,476Cr
9602+227 (2.42%)
9312.50
9740
2,54,764Cr
4928.5+88.5 (1.83%)
4848.50
5010
1,89,423Cr
1180.3+20.3 (1.75%)
1152.10
1190.60
1,16,658Cr
1399+4.5 (0.32%)
1364.50
1419
1,11,484Cr
2026.2+72.2 (3.69%)
1963.80
2055.30
1,09,943Cr
2500+199.3 (8.66%)
2303
2504.30
1,01,712Cr
1200.4+15.4 (1.30%)
1185
1222
1,01,005Cr
1716-18 (-1.04%)
1689.30
1740
99,253Cr
2100.7+17.7 (0.85%)
2080
2135
96,031Cr
1295.3+115.5 (9.79%)
1179.80
1353.50
7,436Cr

Innova Captab Ltd Annual Results Key Takeaways

Operating profit (before other income, interest and exceptional items) was ₹75.13Cr; with other income of ₹2.01Cr, profit before interest and tax came to ₹63.41Cr. Interest expense was ₹4.43Cr; PBT before exceptional items stood at ₹58.98Cr. Cost mix (full year): raw materials ₹838.16Cr; employee cost ₹167.2Cr; depreciation ₹11.71Cr; other expenses ₹397.73Cr. Basis: consolidated annual results.

Innova Captab Ltd Quaterly Results Key Takeaways

Innova Captab Ltd reported ₹470.85Cr total income from operations in Jun 2026, softer than ₹447.8Cr in Mar 2026 but higher than ₹351.54Cr in Jun 2025. Operating profit (before other income, interest and exceptional items) was ₹75.13Cr; with other income of ₹2.01Cr, profit before interest and tax came to ₹63.41Cr. Interest expense was ₹4.43Cr, taking profit before tax to ₹58.98Cr. After tax of ₹14.86Cr, profit after tax stood at ₹44.13Cr (vs ₹40.35Cr in Mar 2026 and ₹31.02Cr in Jun 2025).